Brucellar epididymo-orchitis in southeastern part of Turkey: an 8 year experience

dc.contributor.authorCelen, Mustafa Kemal
dc.contributor.authorUlug, Mehmet
dc.contributor.authorAyaz, Celal
dc.contributor.authorGeyik, Mehmet Faruk
dc.contributor.authorHosoglu, Salih
dc.date.accessioned2024-04-24T17:18:10Z
dc.date.available2024-04-24T17:18:10Z
dc.date.issued2010
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjective: the different clinical and laboratory features and response to treatment of patients with acute brucellar epididymo-orchitis (BEO) reporting to the reference hospital in Southeastern Anatolia of Turkey. Material and methods: in this study, 27 male patients with brucellosis, who presented with epididymitis or epididymo-orchitis (EO) at the university hospital in Diyarbakir from 1998 to 2006, were included. They were compared with the other male patients. Positive blood culture or high agglutination titers of >= 1/160 and positive clinical manifestations of brucellosis were the main criteria for diagnosing brucellosis. Results: fourteen patients had unilateral EO. Leukocytosis was present in 10 patients; all of them had initial agglutination titers of >= 1/160 and 10 patients had a positive blood culture. All patients received combined therapy with streptomycin for the first 21 days (or oral rifampicin for 6-8 weeks) with doxycycline or tetracycline for 6-8 weeks. All showed improvement, fever subsided in 3-7 days, and the scrotal enlargement and tenderness regressed. Only one patient had a relapse within one year. Conclusion: in brucellosis-endemic areas, clinicians encountering EO should consider the likelihood of brucellosis. In this study, young age was the most common risk factor, and leukocytosis and high CRP level were the most common laboratory findings. Most cases were unilateral. All patients responded to medical management very well. Conservative management with combination antibiotic therapy was adequate for managing BEO. Conclusively, brucellosis must be considered as a cause of orchitis, especially in endemic regions like Turkey.en_US
dc.identifier.doi10.1590/S1413-86702010000100021
dc.identifier.endpage115en_US
dc.identifier.issn1413-8670
dc.identifier.issn1678-4391
dc.identifier.issue1en_US
dc.identifier.pmid20428665
dc.identifier.scopus2-s2.0-77954767768
dc.identifier.scopusqualityQ2
dc.identifier.startpage109en_US
dc.identifier.urihttps://doi.org/10.1590/S1413-86702010000100021
dc.identifier.urihttps://hdl.handle.net/11468/18647
dc.identifier.volume14en_US
dc.identifier.wosWOS:000279113600021
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherElsevier Brazilen_US
dc.relation.ispartofBrazilian Journal of Infectious Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEpididymo-Orchitisen_US
dc.subjectBrucellosisen_US
dc.subjectTurkeyen_US
dc.subjectMedical Treatmenten_US
dc.titleBrucellar epididymo-orchitis in southeastern part of Turkey: an 8 year experienceen_US
dc.titleBrucellar epididymo-orchitis in southeastern part of Turkey: an 8 year experience
dc.typeArticleen_US

Dosyalar